Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-22

Clinical Trial Update: Double-blind, Randomized, Non-inferiority Trial in Atopic Dermatitis: Comparison of Lipikar Balm and Relipid+ Balm in the Treatment of Mild to Moderate Atopic Dermatitis in Children and Adults [NA]

View source ↗

Summary

This clinical trial update describes a double-blind, randomized non-inferiority study comparing Lipikar Balm and Relipid+ Balm for mild-to-moderate atopic derma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lipikar Balm
  • Relipid+ Balm

Snippet

Sponsor: University Hospital, Caen | Conditions: Atopic Dermatitis, Emollients | NA | Status: NOT_YET_RECRUITING